Publication | Closed Access

Monocyte activation by an oral immunomodulator (bestatin) in lymphoma patients following autologous bone marrow transplantation

Cell TherapyMonocyte ActivationImmunologyImmunotherapyHematological MalignancyStem Cell TransplantationHematologyRadiation OncologyLymphoma PatientsCell TransplantationHealth SciencesLymphoid NeoplasiaTransplantationMarrow TransplantationAutoimmunityOral ImmunomodulatorTumor MicroenvironmentMalignant Blood DisorderMedicine